Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Whole-virus vaccine development by continuous culture on a complementing host

D Kong1, J Yin

  • 1Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755-8000, USA.

Bio/Technology (Nature Publishing Company)
|June 1, 1995
PubMed
Summary

An adaptive strategy using bacteriophage T7 evolved faster-replicating variants. These whole-virus vaccine candidates were immunogenically similar to wildtype, suggesting a viable vaccine development approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Association between the incidence of hemorrhagic fever with renal syndrome and meteorological factors in Shenzhen City from 2012 to 2019].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2026
Same author

Streaming Fluid Motion Within a Laterally Oscillating Sphere With Density Stratification.

The quarterly journal of mechanics and applied mathematics·2026
Same author

[Antibacterial activity of the antifungal peptide Mt6 - 21DLeu derived from <i>Musca domestica</i> against <i>Acinetobacter baumannii</i> and the underlying mechanisms].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2025
Same author

[Epidemiological characteristics of dengue fever in Shenzhen City in 2024].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2025
Same author

A Population Pharmacokinetic Analysis for Piperacillin/Tazobactam in Patients with End-Stage Kidney Disease Undergoing Intermittent Haemodialysis: Extension of a General-Purpose Model.

Clinical pharmacokinetics·2025
Same author

Risk factors for infection in patients undergoing shoulder arthroscopy: a systematic review and meta-analysis.

The Journal of hospital infection·2024

Area of Science:

  • Virology
  • Vaccine Development
  • Biotechnology

Background:

  • Developing safe and effective whole-virus vaccines is a critical area of research.
  • Adaptive strategies offer a novel approach to vaccine design.
  • Bacteriophage T7 serves as a robust model system for studying viral evolution.

Purpose of the Study:

  • To evaluate an adaptive strategy for generating whole-virus vaccines.
  • To assess the feasibility of using bacteriophage evolution for vaccine development.
  • To characterize the properties of evolved phage variants.

Main Methods:

  • Cultivating wildtype phage T7 in a continuous stirred-tank reactor (CSTR) with a recombinant E. coli host.
  • Monitoring phage evolution over 180 generations.

Related Experiment Videos

  • Analyzing evolved phage variants for host-ranges, restriction patterns, and growth rates.
  • Assessing the immunogenicity of the fittest variant through antiserum cross-reactivity.
  • Main Results:

    • A diversity of phage variants emerged, with fitter variants outcompeting the wildtype.
    • The fittest variant exhibited a 12% genome deletion and doubled replication speed compared to wildtype.
    • This optimized variant required complementation by the recombinant host for growth.
    • Immunological assays showed the fittest variant was indistinguishable from the wildtype.

    Conclusions:

    • The adaptive strategy successfully generated fitter bacteriophage variants.
    • The evolved variants, particularly the fittest one, demonstrate potential as safe whole-virus vaccine candidates.
    • This study supports the feasibility of using adaptive evolution for developing novel vaccines.